Latest News about GILD
Recent news which mentions GILD
Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks
Today 16:22 EDT
From Benzinga
From Benzinga
From Benzinga
A Closer Look at Gilead Sciences's Options Market Dynamics
March 27, 2025
Tickers
GILD
From Benzinga
From Benzinga
Trump Administration Weighs Deep Cuts To Domestic HIV Prevention Programs, Gilead Stock Slides
March 19, 2025
From Benzinga
Gilead Presents New HIV Treatment And Cure Research Data
March 12, 2025
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
P/E Ratio Insights for Gilead Sciences
March 07, 2025
From Benzinga
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
March 06, 2025
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
February 18, 2025
From Benzinga
From Benzinga
Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch For HIV Prevention
February 12, 2025
From Benzinga
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
February 12, 2025
From Benzinga
Gilead Sciences, Upstart, Mercury General, Confluent And Other Big Stocks Moving Higher On Wednesday
February 12, 2025
From Benzinga
Gilead Sciences (GILD) Q4 2024 Earnings Call Transcript
February 11, 2025
Tickers
GILD
From Motley Fool
Gilead Sciences Shares Push Higher After Q4 Report: Here's Why
February 11, 2025
Tickers
GILD
From Benzinga
Gilead Sciences Beats Q4 EPS Forecast
February 11, 2025
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.